Postgraduate Course, Parts 1–4: Advancing Hepatology—Breakthroughs Shaping Tomorrow’s Care (Ticketed)

Part 1: Liver Fat Comes Out of the Shadows—Transforming Care in Steatotic Liver Disease Steatotic liver disease now represents the most prevalent spectrum of liver disorders encountered in clinical practice worldwide. Rapid advances in disease nomenclature, epidemiology, pathophysiology, and therapeutics have fundamentally changed how clinicians evaluate and manage these patients. Presenters review the evolving natural history and global burden of steatotic liver disease with a focus on metabolic dysfunction–associated and alcohol-associated liver disease. Faculty translate emerging evidence into practical strategies for risk stratification, treatment selection, and longitudinal management, including referral considerations for liver transplantation. The session concludes with interactive, board-style questions designed to reinforce key concepts and highlight common clinical pitfalls. Part 2: The Many Ways the Liver Fails—Contemporary Approaches to Decompensation and Failure Liver failure encompasses a diverse set of clinical syndromes with significant morbidity and mortality. Presenters explore recent advances in understanding the dynamic processes of hepatic decompensation and recompensation. Expert faculty address evidence-based approaches to managing the major complications of portal hypertension—including ascites, variceal bleeding, and hepatic encephalopathy—as well as emerging insights into noncirrhotic portal hypertension. The session concludes with a modern framework for evaluating and managing acute liver failure and acute-on-chronic liver failure, supported by interactive, board-style questions to consolidate learning. Part 3: We Have a Medicine for That—Navigating Therapeutic Advances in Liver Disease The pace of therapeutic innovation in hepatology continues to accelerate, creating both opportunity and complexity for practicing clinicians. Presenters focus on areas with the most transformative recent advances and highest impact on patient outcomes. Topics include: contemporary management of chronic cholestatic liver disease; advances in antiviral therapy for hepatotropic viral infections; optimization of renal function and fluid balance in persons with cirrhosis; and evolving systemic and locoregional therapies for liver-related malignancies. Interactive, board-style questions are utilized to emphasize clinical decision-making and guideline-concordant care. Part 4: Not Every Fix Is a Pill—Innovations Redefining Hepatology Practice Some of the most impactful advances in hepatology extend beyond pharmacotherapy. Faculty for this forward-looking session highlight innovations reshaping the delivery of liver care. Presenters explore the use of telehealth and digital tools to expand access to care; the emerging role of artificial intelligence in leveraging electronic medical records; advances in noninvasive testing to improve diagnostic accuracy; and the rapidly evolving field of machine perfusion in solid organ transplantation. The session concludes with interactive, board-style questions to translate innovation into clinical practice.